Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.
GroupID/ KindredID: 137CA
DiseaseAssertion: VHL
GroupSize: N/A
GroupNumberMales: N/A
GroupNumberFemales: N/A
GroupEthnicity: N/A
GroupAgeRange: N/A
GroupInfo: This germline familial VHL mutation was taken from the Cambridge, Department of Pathology database, with an unknown number of members belonging to Family ID 137CA. Table 4 lists all ID and mutations associated with individuals with pheochromocytoma.
GroupPresentingHPOs: HP:0002666 (pheochromocytoma)
GroupHPOFreeText: Described as a VHL family with pheochromocytoma. Other phenotypes are likely, including renal cell carcinoma, however not detailed here.
GroupNotHPOs: N/A
GroupNotHPOFreeText: N/A
GroupPreviousTesting: N/A
PreviouslyPublished: N/A
SupplementalData: N/A
Variant: p.R167G (c.499C>G)
LegacyVariant: p.R167G (c.712C>G)
CaseProblemVariantFreeText: N/A
ClinVarID: 2219 https://www.ncbi.nlm.nih.gov/clinvar/variation/2219
CAID: N/A
gnomAD: N/A
VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by location between codons 157 and 189.
MutationType: missense_variant; transversion
CivicName: R167G (c.499C>G)
MultipleGeneVariants: N/A